Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2081770 | Drug Discovery Today: Disease Mechanisms | 2011 | 6 Pages |
Abstract
Red blood cells, currently obtained from donors, represent the most common form of cell-based therapy. A better understanding of normal erythropoiesis is leading to improved multi-step protocols for the in vitro generation of fully mature red cells. The extensive in vitro expansion of embryonic erythroblasts and development of erythroid precursors as a potential transfusion product may help to deal with issues of scale and eventually find a place in the treatment of patients with acute and chronic anemias.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Anna Rita Migliaccio, James Palis,